Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
R. Emili
Observed names:
Emili R,
Emili R.,
Emili, R.,
R Emili
Observed institutions:
Università di Camerino,
University of Urbino,
University of Perugia,
Ospedali Riuniti Marche Nord
OpenAlex ID:
A5109489643
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario
2022
·
L. Cantini
, G. Mentrasti
, et al.
·
ESMO Open
·
64
PDF
52nd ANMCO Congress Abstracts e-Posters
2021
·
Flori, M.
, Pietropaolo, F.
, et al.
·
European Heart Journal Supplements
·
10
PDF
Erratum to ‘Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario’
2022
·
L. Cantini
, G. Mentrasti
, et al.
·
ESMO Open
·
6
PDF
Lipidomics and Nutrylipidomics in Oncology: Review of the Literature
2018
·
Virgili E
, Emili R
, et al.
·
Journal of Bioinformatics and Systems Biology
·
3
PDF
OA01.02 Impact of COVID-19 Outbreak on Lung Cancer Diagnosis and Continuum of Care: Data From an Italian Multicenter Study
2021
·
L. Cantini
, G. Mentrasti
, et al.
·
Journal of Thoracic Oncology
·
2
PDF
[Metastatic gastric cancer successfully treated with surgery and chemotherapy. Case report].
2010
·
M Gunnellini
, L Graziosi
, et al.
·
PubMed
·
2
181P A randomized controlled trial on the efficacy of supervised exercise training in reducing IGF-1 levels in breast cancer survivors of the Movis’ cohort
2022
·
M. Bocconcelli
, V. Natalucci
, et al.
·
Annals of Oncology
·
1
PDF
Soy Intake and Breast Cancer
2018
·
Virgili E
, Calza L
, et al.
·
Journal of Health & Medical Informatics
·
1
1898P Multicenter prospective study of programmed death 1 (PD-1) single-nucleotide polymorphisms (SNPs) in patients with metastatic lung adenocarcinoma (MLA) treated with pembrolizumab (P)
2025
·
R. Chiari
, A. Ruzzo
, et al.
·
Annals of Oncology
Assessment of breast cancer survivors’ dietary patterns: Focus on nutritional quality of the diet
2023
·
G. Vici
, G. Annibalini
, et al.
·
Clinical Nutrition ESPEN
PDF
EP17.06-01 COVID-19 Long-Lasting Effect on Lung Cancer Diagnoses in Italy: Update of the Real-World Multicenter COVID-DELAY Study
2023
·
G. Mentrasti
, V. Cognigni
, et al.
·
Journal of Thoracic Oncology
PDF
2206P Detection of circulating KRAS4A and KRAS4B isoforms in patients with metastatic lung adenocarcinoma treated with pembrolizumab or chemotherapy plus pembrolizumab by liquid biopsy: Clinical impact and association with circulating PD-L1
2023
·
S. Palladino
, A. Ruzzo
, et al.
·
Annals of Oncology
PDF
AIOM Abstract
2023
·
Emili R.
, Vagnini D.
, et al.
·
Tumori Journal
238P Beneficial effects of exercise in oncology - MoviS: ‘Movement and Health Beyond Care’
2020
·
R. Emili
, V. Natalucci
, et al.
·
Annals of Oncology
PDF
Improvement in heart rate variability, cardiorespiratory fitness and quality of life in breast cancer survivors across the covid-19 pandemic: insight from the "movement and health beyond care" (MOVIS) clinical trial
2020
·
Marco Flori
, R. Emili
, et al.
·
University of Groningen research database (University of Groningen / Centre for Information Technology)
Health-related quality of life, heart rate variability and physical fitness in breast cancer patients during the COVID-19 lockdown: The impact of a lifestyle program ('MoviS Project, movement and health beyond the care' (CESU approval n. 21/10.07.2019)
2020
·
R. Emili
, Valentina Natalucci
, et al.
·
Tumori
Prospects in the field of pharmacotherapies for Down syndrome
2017
·
R. Emili
, Renata Bartesaghi
·
Clinical and Experimental Pharmacology
Molecular remission to imatinib-IFN-alpha combination or imatinib monotherapy in chronic myeloid leukemia (CML) patients
2007
·
A. Liberati
, M. Schippa
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
20
Citation count:
89
H-index:
3
I10-index:
2
Year
Topic
Type